Advertisement

Topics

Lava Therapeutics Company Profile

05:06 EST 19th January 2019 | BioPortfolio

Lava Therapeutics’ proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Our first-in-class immuno-oncology approach activates Vγ9Vδ2 T cells upon binding to membrane-expressed tumor targets. Lava’s vision is to develop therapeutics for the curative treatment of cancer. Founded in 2016, Lava Therapeutics is advancing cutting-edge research originating from the group of Dr. Hans van der Vliet at the VU University Medical Center and Cancer Center Amsterdam. www.lavatherapeutics.com


News Articles [654 Associated News Articles listed on BioPortfolio]

Series A round brings €16mm to Lava Therapeutics

Lava Therapeutics BV raised €16mm ($18.9mm) through its Series A round. Gilde Healthcare and Versant Ventures co-led, with additional participation from MRL Ventures Fund, Lupus Ventures, and Biox B...

Scientists Brew Lava, Blow it up to Better Understand Volcanoes

NewsWhat happens when lava and water meet? Explosive experiments with man-made lava are helping to answer this important question.Contribute

Scientists Brew Lava and Blow it up to Better Understand Volcanoes

NewsExperiments aim to illuminate the physics of lava-water interactions, which can sometimes make eruptions more dangerous.Contributed Author: 

ScienceTake: Watch Scientists Brew Their Own Lava

In controlled experiments, high-speed cameras caught video of explosions that occur when water hits hot liquid rock.

This Biotech Arms Tumor-Busting Cells to Treat Cancer

In the medieval city of ‘s-Hertogenbosch, the Netherlands, Lava Therapeutics is developing a cancer immunotherapy that arms a rare type of immune cell called gamma delta T cells. Mission: Develo...

Lava Therapeutics BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryLava Therapeutics BV Lava Therapeutics is a biotechnology company which develops immune oncology biopharmaceuticals products. Its proprietary V?9Vd2 Tcell engager candidates bind to the conserv...

Printing Ink is Hotter than Lava Flow

NewsPaul Leibinger GmbH & Co. KG has introduced a pigment ink to the market, which allows a clear typeface even at 1000° C. Particles are also kept in suspension through chemical stabilization.

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Nanoparticles that could reprogram a cancer patient's immune system inside their own body. Understanding a mysterious type of brain cell in the hopes of shedding new light on Alzheimer's disease. Reim...

PubMed Articles [494 Associated PubMed Articles listed on BioPortfolio]

Comparative evaluation of the mechanical properties of CAD/CAM dental blocks.

This study compares the mechanical properties of commercially available CAD/CAM (Computer-Aided Design/Computer-Aided Manufacturing) millable dental blocks including Vita Enamic, Lava Ultimate, and MA...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Clinical Trials [171 Associated Clinical Trials listed on BioPortfolio]

One Year Clinical Evaluation of E-max CAD and Lava Ultimate Laminate Veneers

Restoration of anterior teeth using conservative approach allows clinicians to provide porcelain laminate veneers with excellent esthetics without extensive tooth structure removal. lamina...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1295 Associated Companies listed on BioPortfolio]

Lava Therapeutics

Lava Therapeutics’ proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Our first-in-class immuno-onc...

CMEA Ventures

CMEA Ventures is a San Francisco based venture capital firm that was established in 1989 and specializes in high technology, life sciences, and alternative energy investments. We invest in both early ...

Sciessent

Sciessent, located in Wakefield, Mass., is a leader in providing customized solutions that enhance the value of partners’ products. Sciessent’s Agion, Agion Active and A...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Lava Therapeutics" on BioPortfolio

We have published hundreds of Lava Therapeutics news stories on BioPortfolio along with dozens of Lava Therapeutics Clinical Trials and PubMed Articles about Lava Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lava Therapeutics Companies in our database. You can also find out about relevant Lava Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record